Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseRobert Zeiser, Gèrard Socié, Nikolas von Bubnoff et al.|New England Journal of Medicine|2020Cited by 859
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial resultsAlexander M. Lesokhin, Mohamad Mohty|Nature Medicine|2023Cited by 534
One million haemopoietic stem-cell transplants: a retrospective observational studyAloïs Gratwohl, Dietger Niederwieser, Hildegard Greinix et al.|The Lancet Haematology|2015Cited by 434
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantationTobias Feuchtinger, Hermann Einsele, Kathrin Opherk et al.|Blood|2010Cited by 430
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studiesReuben Benjamin, Jackie Chappell, Charlotte Graham et al.|The Lancet|2020Cited by 358